Bangladesh Confirms First Nipah Virus Death of 2024, Sparking Regional Health Concerns
A woman in Bangladesh has died from Nipah virus infection, the World Health Organization (WHO) confirmed, raising alarm among public health officials in the region. The patient, estimated to be between 40 and 50 years old, succumbed to the virus just one day after being hospitalized in January. This incident follows the recent detection of Nipah cases in the eastern Indian state of West Bengal, prompting a reintroduction of heightened border and health surveillance measures in some areas, reminiscent of protocols used during the Covid-19 pandemic.
Rapidly Developing Symptoms and Confirmed Infection
According to authorities, the patient first exhibited symptoms – including fever and headache – on January 21. These initial signs were quickly followed by more severe manifestations such as muscle cramps, loss of appetite, and vomiting. Within days, the patient experienced loss of consciousness, excessive salivation, and seizures, ultimately requiring hospitalization where, despite medical intervention, she could not be saved. Laboratory tests definitively confirmed the presence of the Nipah virus.
Transmission and Ongoing Surveillance
The deceased woman had no reported history of recent travel, but had been regularly consuming raw date palm sap in the weeks leading up to her illness. Experts indicate that Nipah virus is primarily transmitted through the consumption of food contaminated with the saliva or feces of bats. The WHO has reported that 35 individuals who had close contact with the patient are currently under surveillance, with all tests conducted to date returning negative results. As of now, no additional cases have been identified.
High Mortality Rate and Long-Term Health Risks
Nipah virus carries a significant risk, with mortality rates ranging from 40 to 75 percent, according to British health authorities. Even among those who survive infection, lasting neurological problems, recurring seizures, and changes in personality are possible. Furthermore, the virus has the potential to reactivate months, or even years, after the initial infection.
Lack of Vaccine and Treatment Drives Preventative Measures
Currently, there is no approved vaccine or specific treatment available for Nipah virus. This lack of medical countermeasures has prompted several countries – including Malaysia, Thailand, Indonesia, and Pakistan – to increase temperature screening at airports as a preventative measure. A senior official stated that these measures are intended to quickly identify and isolate potential cases, preventing further spread.
